Vatalanib dihydrochloride，又称瓦他拉尼二盐酸盐，是苯胺邻苯二甲酸衍生物，是可口服的VEGFR2/KDR抑制剂，IC₅₀为37 nM，抑制血管生成。Vatalanib dihydrochloride作用于VEGFR1/FLT1、VEGFR2/Flk1和PDGFRβ的IC₅₀值为77 nM、270 nM和580 nM。

参考文献

[1] Wood JM, Bold G, Buchdunger E, et al. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res. 2000 Apr 15;60(8):2178-89(IF:8.378).

[2] Murakami M, Kobayashi S, Marubashi S, et al. Tyrosine kinase inhibitor PTK/ZK enhances the antitumor effects of interferon-α/5-fluorouracil therapy for hepatocellular carcinoma cells. Ann Surg Oncol. 2011 Feb;18(2):589-96. doi: 10.1245/s10434-010-1310-y(IF:3.681).

-25~-15℃保存，有效期3年。